Viridian Therapeutics
VRDN
VRDN
132 hedge funds and large institutions have $1.32B invested in Viridian Therapeutics in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 49 increasing their positions, 43 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
14% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 43
7% more funds holding
Funds holding: 123 → 132 (+9)
0.51% more ownership
Funds ownership: 114.85% → 115.36% (+0.51%)
Holders
132
Holding in Top 10
10
Calls
$1.85M
Puts
$590K
Top Buyers
| 1 | +$160M | |
| 2 | +$50.7M | |
| 3 | +$24.2M | |
| 4 |
VA
VR Adviser
New York
|
+$17.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$17.1M |
Top Sellers
| 1 | -$30.8M | |
| 2 | -$30.8M | |
| 3 | -$25.2M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$14.4M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$13.5M |